期刊文献+

Apolipoprotein C3(-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population 被引量:7

Apolipoprotein C3(-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population
下载PDF
导出
摘要 AIM:To investigate the relationship between Apolipoprotein C3(APOC3)(-455T>C) polymorphism and nonalcoholic fatty liver disease(NAFLD) in the Southern Chinese han population.METHODS:In this prospective case-control study,we recruited 300 NAFLD patients and 300 healthy controls to a cohort representing Southern Chinese han population at The First Affiliated Hospital,Sun Yat-sen University,from January to December 2012. Polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing were used to genotype the APOC3(-455T>C) variants.RESULTS:After adjusting for age,gender,and bodymass index,TC and CC genotypes were found to increase the susceptibility to NAFLD compared to the TT genotype,with adjusted odds ratios(ORs) of 1.77(95%CI:1.16-2.72) and 2.80(95%CI:1.64-4.79),respectively. Further stratification analysis indicated that carriers of the CC genotype was more susceptible to insulin resistance(IR) than those of the TT genotype,with an OR of 3.24(95%CI:1.52-6.92). The CC genotype also was associated with a significantly higher risk of hypertension,hypertriglyceridemia,and low levels of high-density lipoprotein cholesterol(hDL)(P < 0.05). No association was found between the APOC3(-455T>C) polymorphism and obesity,impaired glucose tolerance,hyperuricemia,hypercholesterolemia,or high levels of low-density lipoprotein cholesterol(LDL)(P > 0.05).CONCLUSION:APOC3(-455T>C) genetic variation is involved in the susceptibility to developing NAFLD,IR,hypertension,hypertriglyceridemia,and low hDL in the Southern Chinese han population. AIM:To investigate the relationship between Apolipoprotein C3(APOC3)(-455T>C) polymorphism and nonalcoholic fatty liver disease(NAFLD) in the Southern Chinese han population.METHODS:In this prospective case-control study,we recruited 300 NAFLD patients and 300 healthy controls to a cohort representing Southern Chinese han population at The First Affiliated Hospital,Sun Yat-sen University,from January to December 2012. Polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing were used to genotype the APOC3(-455T>C) variants.RESULTS:After adjusting for age,gender,and bodymass index,TC and CC genotypes were found to increase the susceptibility to NAFLD compared to the TT genotype,with adjusted odds ratios(ORs) of 1.77(95%CI:1.16-2.72) and 2.80(95%CI:1.64-4.79),respectively. Further stratification analysis indicated that carriers of the CC genotype was more susceptible to insulin resistance(IR) than those of the TT genotype,with an OR of 3.24(95%CI:1.52-6.92). The CC genotype also was associated with a significantly higher risk of hypertension,hypertriglyceridemia,and low levels of high-density lipoprotein cholesterol(hDL)(P < 0.05). No association was found between the APOC3(-455T>C) polymorphism and obesity,impaired glucose tolerance,hyperuricemia,hypercholesterolemia,or high levels of low-density lipoprotein cholesterol(LDL)(P > 0.05).CONCLUSION:APOC3(-455T>C) genetic variation is involved in the susceptibility to developing NAFLD,IR,hypertension,hypertriglyceridemia,and low hDL in the Southern Chinese han population.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第38期14010-14017,共8页 世界胃肠病学杂志(英文版)
基金 Supported by Natural Scientific Foundation of Guangdong Province,No.S2012040007685 Doctoral Program Foundation of Institutions of Higher Education of China,No.20120171120090 National Natural Science Foundation of China,No.81301769 and No.81170392
关键词 Apolipoprotein C3 Nonalcoholic fatty liver disease Insulin resistance Metabolic disorder Polymor-phism Apolipoprotein C3 Nonalcoholic fatty liver disease
  • 相关文献

参考文献11

  • 1Tong-Hong Niu,Man Jiang,Yong-Ning Xin,Xiang-Jun Jiang,Zhong-Hua Lin,Shi-Ying Xuan.Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population[J].World Journal of Gastroenterology,2014,20(13). 被引量:8
  • 2S. Lallukka,K. Sevastianova,J. Perttil?,A. Hakkarainen,M. Orho-Melander,N. Lundbom,V. M. Olkkonen,H. Yki-J?rvinen.Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3[J].Diabetologia.2013(4)
  • 3Dinesh Khanna,John D. Fitzgerald,Puja P. Khanna,Sangmee Bae,Manjit K. Singh,Tuhina Neogi,Michael H. Pillinger,Joan Merill,Susan Lee,Shraddha Prakash,Marian Kaldas,Maneesh Gogia,Fernando Perez‐Ruiz,Will Taylor,Frédéric Lioté,Hyon Choi,Jasvinder A. Singh,Nicola Dalbeth,Sanford Kaplan,Vandana Niyyar,Danielle Jones,Steven A. Yarows,Blake Roessler,Gail Kerr,Charles King,Gerald Levy,Daniel E. Furst,N. Lawrence Edwards,Brian Mandell,H. Ralph Schumacher,Mark Robbins,Neil Wenger,Rober.2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J].Arthritis Care Res.2012(10)
  • 4K. Gariani,J. Philippe,F.R. Jornayvaz.Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside[J].Diabetes and Metabolism.2012
  • 5Yan Ding,Ming An Zhu,Zhi Xiao Wang,Jing Zhu,Jing Bo Feng,Dong Sheng Li,Momiao Xiong.Associations of Polymorphisms in the Apolipoprotein APOA1-C3-A5 Gene Cluster with Acute Coronary Syndrome[J].Journal of Biomedicine and Biotechnology.2012
  • 6Philip Greenland,Joseph S. Alpert,George A. Beller,Emelia J. Benjamin,Matthew J. Budoff,Zahi A. Fayad,Elyse Foster,Mark A. Hlatky,John McB. Hodgson,Frederick G. Kushner,Michael S. Lauer,Leslee J. Shaw,Sidney C. Smith,Allen J. Taylor,William S. Weintraub,Nanette K. Wenger.2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults[J].Journal of the American College of Cardiology.2010(25)
  • 7Curtis K. Argo,Stephen H. Caldwell.Epidemiology and Natural History of Non-Alcoholic Steatohepatitis[J].Clinics in Liver Disease.2009(4)
  • 8Jian-Gao Fan,Geoffrey C. Farrell.Epidemiology of non-alcoholic fatty liver disease in China[J].Journal of Hepatology.2008(1)
  • 9Michael Miller,Jeffrey Rhyne,Hegang Chen,Valerie Beach,Richard Ericson,Kalpana Luthra,Manjari Dwivedi,Anoop Misra.APOC3 Promoter Polymorphisms C-482T and T-455C Are Associated with the Metabolic Syndrome 1[J].Archives of Medical Research.2007(4)
  • 10K. G. M. M.Alberti,P.Zimmet,J.Shaw.Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation[J]. Diabetic Medicine . 2006 (5)

二级参考文献10

  • 1Harmeet Malhi,Gregory Gores.Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease[J]. Semin Liver Dis . 2008 (04)
  • 2I. Pinchuk,H. Shoval,Y. Dotan,D. Lichtenberg.Evaluation of antioxidants: Scope, limitations and relevance of assays[J].Chemistry and Physics of Lipids.2012(6)
  • 3JenniHyysalo,IvanaStojkovic,AnnaKotronen,AnttiHakkarainen,KseniaSevastianova,JanneMakkonen,NinaLundbom,AilaRissanen,Ronald MKrauss,OlleMelander,MarjuOrho‐Melander,HanneleYki‐J?rvinen.Genetic variation in PNPLA3 but not APOC3 influences liver fat in non‐alcoholic fatty liver disease[J].Journal of Gastroenterology and Hepatology.2012(5)
  • 4Yong JianZHOU,Yu YuanLI,Yu QiangNIE,Chun MingHUANG,Chuang YuCAO.Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study[J].Journal of Digestive Diseases.2012(3)
  • 5Luca Valenti,Valerio Nobili,Ahmad Al-Serri,Raffaela Rametta,Julian B.S. Leathart,Marco A. Zappa,Paola Dongiovanni,Anna L. Fracanzani,Arianna Alterio,Giancarlo Roviaro,Ann K. Daly,Silvia Fargion,Christopher P. Day.The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver[J].Journal of Hepatology.2011(6)
  • 6ShivakumarChitturi,Vincent Wai‐SunWong,GeoffFarrell.Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground[J].Journal of Gastroenterology and Hepatology.2011
  • 7Stefano Romeo,Federica Sentinelli,Valentina M Cambuli,Michela Incani,Tiziana Congiu,Vanessa Matta,Sabrina Pilia,Isabel Huang-Doran,Efisio Cossu,Sandro Loche,Marco G Baroni.The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life[J].Journal of Hepatology.2010(2)
  • 8Chunyu Zheng,Christina Khoo,Jeremy Furtado,Frank M. Sacks.Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype[J].Circulation.2010(15)
  • 9Martijn C.G.J. Brouwers,Marleen M.J. van Greevenbroek,Rita M. Cantor.Heritability of Nonalcoholic Fatty Liver Disease[J].Gastroenterology.2009(4)
  • 10Anna Kotronen,Jukka Westerbacka,Robert Bergholm,Kirsi H. Pietil?inen,Hannele Yki-J?rvinen.Liver Fat in the Metabolic Syndrome[J].The Journal of Clinical Endocrinology & Metabolism.2007(9)

共引文献25

同被引文献13

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部